Table 1.

ARVs available for term infants in first four weeks of life and for preterm newborn infants

	Term	Preterm	Comments
Reverse transcriptase inhibitors
Zidovudine	X	X	IV formulation available
Lamivudine	X		Dosage available for first month
Emtricitabine	X		Dosage from 0 to 3 months
Stavudine	X
Non-nucleoside reverse transcriptase inhibitors
Nevirapine	X	X	Dosages available for prevention only
Protease inhibitors
Lopinavir-ritonavir	X (Recommended only after 2 weeks of age and 42 weeks post-conception)		If used earlier than 42 weeks post-conception age, therapeutic drug monitoring and clinical and cardiac monitoring recommended

From Ref. [11].